Mosaic Plans Mid-2000 Trials Of Hybriscan Rapid Blood Platelet Bacteria Test
This article was originally published in The Gray Sheet
Executive Summary
Mosaic Technologies plans to begin clinical trials in mid-2000 of an assay for bacteria in blood platelets, the firm says. The assay uses a combination hybridization/electrophoresis technology that dramatically accelerates hybridization, thereby yielding a low to moderate complexity test that can be performed in 30 minutes or less, Mosaic claims.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.